Novo Nordisk's Awiqli Receives FDA Approval As The First And Only Once-Weekly Insulin For Children 10 Years Of Age And Older With Type 2 Diabetes

Benzinga

2026.10.23 18:24 (GMT+0)

Открыть на Benzinga